Broadview Waste Solutions, Inc.

Broadview Waste Solutions, Inc., a self-certified small disadvantaged business based in Baltimore, Maryland, provides hazardous materials disposal, pharmaceutical waste management, and specialized environmental remediation services to federal civilian agencies as a prime contractor, competing predominantly under total small business set-asides.

Broadview operates across five customer agencies, with customer concentration heavily skewed toward the Department of Health and Human Services. The top two customers by combined potential value account for all $11.9 million in recent awards: the Department of Veterans Affairs Veterans Integrated Service Network 5 holds three awards worth $9.9 million (primarily a $3.2 million single-award BPA running through September 2027), and HHS's Office of the Assistant Secretary for Administration holds fourteen awards totaling $2 million. The split between the two rankings reflects the magnitude difference between HHS's frequent small purchase orders (sub-$250 thousand) and the VA's larger vehicle contract. A one-off award from NIST for confined space cleaning of a gasoline storage tank ($7.2 thousand, total small business set-aside, July 2025) and a Fish and Wildlife Service hazardous materials disposal engagement ($7 thousand, no set-aside, September 2023) round out the agency footprint.

Broadview's capability portfolio centers on disposal and destruction of controlled, expired, and hazardous medical materials. Representative prime work includes a $1.1 million HHS transport and certification contract for destruction of 96 truckloads of unused needles (August 2023, total small business set-aside), a $241.5 thousand HHS purchase order for COVID-19 vaccine and related-supplies destruction and transport (August 2023, total small business set-aside), a $127.1 thousand HHS disposal contract for expired material (January 2026, total small business set-aside), a $27.8 thousand HHS order for H5N1 and H7N9 influenza material destruction (April 2024, total small business set-aside), and a $3.1 million VA BPA call for general hazardous waste services running through September 2026 with a government-paid rate of $680.28 per hour derived from FY2023 invoicing. Work spans disposal of influenza materials, antiviral medications (peramivir), expired medical countermeasures (MCDM, Cipro, iodine), RSDL lotion, unused needles and syringes, and biological hazard waste. All work is performed at Broadview's facility in Curtis Bay, Baltimore, Maryland.

Broadview operates entirely as a prime contractor (100% of awards), with no subcontractor engagement reported across its award footprint. Activity peaked in fiscal 2023 with ten awards, then declined sharply to two awards in each of 2024, 2025, and 2026. One award—the VA BPA—faces recompete or expiration in the next twenty-four months (combined potential value $3.1 million). Across the top NAICS categories, Hazardous Waste Treatment and Disposal (12 awards) dominates the portfolio, with Hazardous Waste Collection (4 awards) and Remediation Services (1 award) providing secondary work streams. The SCI dataset captures minimal labor activity: $124 thousand in invoiced revenue across 0.1 FTEs in FY2023, with zero SCI-reportable dollars in FY2024, reflecting the purchase-order nature of the work and Broadview's focus on goods and materials handling rather than labor-intensive service contracts above the $150 thousand reporting threshold.

Hazardous Waste Collection, Waste Transportation